Member Info for equitrder

Didn't realize they were covering the stock. Stifel Nicolaus reaffirmed their buy rating on shares of Amryt Pharma PLC (LON:AMYT) in a research report released on Monday morning. Stifel Nicolaus currently has a GBX 49 ($0.61) target price on the stock.

Cathal Friel leaving the board is actually a good thing.He is the biggest shareholder and by leaving the board of directors it show his trust in the management team. He is also not a pharmaceutical guy.

An acquisition is acquired .. They are paying royalty payments for Lojuxta. Not sure you could say Fastnet was acquired it was a reverse merger

A cutting from the latest release, 'Key to the short- and medium-term prospects of the firm is a skin treatment called Episalvan, developed by German specialist Birken - one of a trio of acquisitions Amryt has made so far.' Who is the THIRD Acquisition??

At this rate of decline we might be back where we started by Friday.

Very lame effort by Mrs.Merkel after Trump and his cronies basically called Germany a currency manipulator.

There is a new video on the website. Nothing we don't know already

Well we won't know that until later this year or next year. Hopefully before then we will have a few more partnerships and start building revenue. The company just got going its a bit early to be predicting its demise.

I think Merkel will get the heave-ho before the elections and I just can't see the French electing a banker to Champs Elysees in the current environment.

America has been split since Bill Clinton,Trump just shows the true level of the split. Just came back from Manhattan and the impression I got was give him a chance.Most people are saying this is a storm in a teacup by the media. Trump is right Chuck Schumer's tears are fake.. Mrs. May is still a lightweight though with the hand holding she is now tied to Trump's hip

Thinice, I will soon just have a few questions I need answered first. Btw its still a long shot.

Radar its all a gamble. We can only hope management know what they are doing from past experience. If we get to .25 I'll have a double and I will take 1/2 off the table and let the rest ride.

Oh that was 20 years in the making. It does show the majors are willing too pay up for orphan pharma. Something interesting happened recently to another company that management are connected to.It could be a backdoor entry to the Nasdaq for Amryt and its BOD's who have deep pockets

J&J Seals $30 Billion Actelion Deal to Enter Rare Disease Arena Actelion shareholders to get $280/share in cash in deal Drugmakers expect deal to be completed in second quarter Johnson & Johnson agreed to buy Actelion Ltd. for $30 billion and spin off the Swiss drugmaker’s research and development operations, clinching its largest deal ever to become a leader in medicines treating a rare type of high blood pressure. J&J, already the world’s biggest maker of health-care products, is fulfilling its goal of adding a new drug category with the transaction and dealing a blow to France’s Sanofi, which had also sought to acquire Actelion. The deal is expensive compared to recent industry takeovers such as Pfizer Inc.’s acquisition of Medivation Inc. and AbbVie Inc.’s purchase of Pharmacyclics Inc., according to an analysis from Bloomberg Intelligence. J&J will begin a tender offer to buy shares of Allschwil, Switzerland-based Actelion for $280 each in cash, the companies said in a statement. The price, which equals 280.08 Swiss francs, is 23 percent above Wednesday’s closing level. The R&D operations will be spun off to Actelion shareholders as a new publicly traded company, with J&J keeping a 16 percent stake

Its actually funny 'deadcat' I had you filtered out along with 'leamke' (another bright spark) and only saw your comment because I wasn't logged in.

Well deadcat IF you look at ALL the first world cities all around Europe they are ALL having housing problems!!!! Why do you think? If you took your head out of your a s s you would see mass immigration from all the eastern block countries and Southern Europe to countries with strong Service Sectors and Manufacturing.The minimum wage in Lithuania is 350 per month and in Ireland it is 1600 per month.Hence the MASS EXODUS putting a huge strain on housing in the developed counties of Europe. Why dont you make your argument rather than CONSTANTLY spewing Verbal Diarrhea!!!

I really thought we would test .24 before a big sell off. No Interest No volume

To much pressure

Sure the French might be the next ones to leave. I doubt Le Pen will win but if it happens its game over. I for one would welcome it. Free movement of people is putting way to much on our cities. Student accommodation 950 a month (for a box room sharing)is a complete joke.

Maybe it's because Sterling is collapsing again. I personally think Theresa May is probably the worst leader of the UK in my lifetime.